Business Context and Reporting Period
Company: Entegris, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended April 2, 2011
Business Overview: Entegris is a leading provider of products for purifying, protecting, and transporting critical materials used in semiconductor and high-technology manufacturing. The company operates through three segments: Contamination Control Solutions (CCS), Microenvironments (ME), and Specialty Materials (SMD).
Key Financial Metrics
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Sales | $203.1 million | $160.5 million |
| Gross Profit | $88.3 million | $73.2 million |
| Gross Margin | 43.5% | 45.6% |
| Operating Income | $37.3 million | $22.3 million |
| Net Income (Attributable to Entegris) | $29.2 million | $16.6 million |
| Diluted EPS | $0.22 | $0.12 |
| Cash and Cash Equivalents | $142.6 million | $73.3 million (end of period) |
| Operating Cash Flow | $11.1 million | $28.0 million |
| Debt | $0 (No outstanding borrowings) | $0 (No outstanding borrowings) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 27% year-over-year to $203.1 million, marking the eighth consecutive quarter of sales growth. This included a favorable foreign currency translation effect of $8.1 million; excluding this, sales rose 21%.
- Profitability: Net income increased 76% to $29.2 million. Operating income rose 68% to $37.3 million, driven by higher sales volume despite a slight compression in gross margin (43.5% vs. 45.6% in Q1 2010).
- Expense Management: Selling, general, and administrative (SG&A) expenses remained flat year-over-year at $35.8 million, declining as a percentage of sales from 22.3% to 17.6%. Engineering, research, and development (ER&D) expenses increased 16% to $12.5 million.
- Amortization: Amortization of intangible assets decreased significantly to $2.7 million from $4.3 million in the prior year, as certain acquired assets became fully amortized.
- Cash Flow: Operating cash flow decreased to $11.1 million from $28.0 million in the prior year, primarily due to a $10.1 million increase in accounts receivable and a decrease in accrued liabilities.
Guidance, Outlook, and Risks
- Outlook: Management expects cash and cash equivalents, combined with available credit facilities and operating cash flow, to be sufficient to meet working capital and investment requirements for the next twelve months.
- Segment Performance: All three segments reported sales increases. CCS sales rose 31%, ME sales rose 15%, and SMD sales rose 27%. CCS segment profit increased 41%, while ME segment profit remained flat due to lower gross margins and higher operating expenses.
- Risk Factors:
- Japan Earthquake/Tsunami: The filing notes potential future negative impacts on the supply chain, product delivery, costs, and demand due to the recent events in Japan, which historically account for approximately 20% of revenues.
- Market Cyclicality: Sales are subject to industry cyclicality, technological change, and competition.
- Foreign Currency: Results are sensitive to fluctuations in foreign exchange rates, particularly the Japanese yen and Taiwanese dollar.
- Legal Proceedings: The company settled all pending patent infringement litigation with Pall Corporation in January 2011, allowing both parties to continue manufacturing existing product lines.
Investor Verification Checklist
- Japan Exposure: Verify the specific impact of the Japan earthquake and tsunami on Q2 2011 supply chains and customer demand, given the 20% revenue exposure.
- Margin Trends: Monitor whether the gross margin compression (down 210 basis points) is a temporary mix issue or a structural shift due to raw material costs or pricing pressure.
- Working Capital: Review the $10.1 million increase in accounts receivable and the corresponding Days Sales Outstanding (61 days) to ensure collection efficiency remains stable as sales grow.
- Capital Expenditures: Confirm that capital spending remains within the $30.0 million limit for the first ten months of 2011 imposed by the revolving credit facility.
- Non-GAAP Measures: Review the reconciliation of Adjusted EBITDA ($46.8 million) and Adjusted Operating Income ($40.0 million) to understand management's view of core operating performance excluding amortization.